Plasma folic acid cutoff value, derived from its relationship with homocyst(e)ine

Clinical Chemistry

Volumn 44, Issue 7, 1998, Pages 1545-1550

  Brouwer, D A Janneke ^a   Welten, H T M Erik ^a   Reijngoud, Dirk Jan ^a   Van Doormaal, Jasper J ^a   Muskiet, Frits A J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; METHIONINE;

ADULT; AGED; ARTICLE; DIET SUPPLEMENTATION; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERHOMOCYSTEINEMIA; MALE; VITAMIN DEFICIENCY;

EID: 0031832051     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.7.1545     Document Type: Article

References (29)

1. Selhub ., Jacques PF, Bostom AG, D'Agostino RB, Wilson PWF, Belanger AJ, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286-91.
2. Gey KF, Moser UK, Jordan P, Stähelin HB, Eichholzer M, Lüdin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr 1993;57:787S-97S.
3. Compston JE. The role of vitamin D and calcium supplementation in the prevention of osteoporotic fractures in the elderly. Clin Endocrinol 1995;43:393-405.
4. Solberg HE. Approved recommendation (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits. Clin Chim Acta 1987;170:S13-32.
5. van den Berg H. Functional vitamin status assessment. In: Somogyi JC, Elmadfa I, Walter P, eds. New aspects of nutritional status. Bibl Nutr Dieta 1994;51:142-9.
6. Finkelstein JD. Methionine metabolism in mammals [Review]. J Nutr Biochem 1990;1:228-37.
7. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-8.
8. 12, and folate. Am J Epidemiol 1996;143:845-59.
9. Brattström LE, Israelsson B, Jeppsson J-O, Hultberg BL. Folic acid-an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Investig 1988;48:215-21.
10. Rasmussen K, Møller J, Lyngbak M, Pedersen A-MH, Dybkjær L. Age- and gender-specific reference intervals for total homocysteine anc methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem 1996;42:630-6.
11. Wilcken De, Dudman NP, Tyrrell PA, Robertson MR. Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease. Metabolism 1988;37:697-70.
12. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994;124:1927-33.
13. Franken DG, Boers GHJ, Blom HJ, Trijbels FJM, Kloppenborg PWC. Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler Thromb 1994;14:465-70.
14. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes [Review]. JAMA 1995;274:1049-57.
15. Arnesen E, Refsum H, Bønaa KH, Ueland PM, Førde OH, Nordrehaug JE. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995;24:704-9.
16. Verhoef P, Kok FJ, Kruyssen DACM, Schouten EG, Witteman JCM, Grobbee DE, et al. Plasma total homocysteine, B vitamins and risk of coronary atherosclerosis. Arterioscler Thromb Vase Biol 1997; 17:989-95.
17. Graham IM, Daly LE, Refsum HM, Robinson K, Brattström LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277:1775-81.
18. Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-6.
19. Jagerstad M, Pietrzik K. Flair Concerted Action No 10 Status Papers. Folate. Int J Vitam Nutr Res 1993;63:285-9.
20. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.
21. 6) in whole blood by high-performance liquid chromatography (HPLC). Int J Vitam Nutr Res 1981;51:216-22.
22. 6 nutritional status. J Chromatogr 1985;342:277-84.
23. Whitby LG, Smith AF, Beckett GJ. Lecture notes in clinical chemistry, 4th ed. Oxford: Blackwell Scientific Publications, 1988:17-37.
24. Garg UC, Zheng Z-J, Folsom AR, Moyer YS, Tsai MY, McGovern P, Eckfeldt JH. Short-term and long-term variability of plasma homocysteine measurement. Clin Chem 1997;43:141-5.
25. Stevens J. Applied multivariate statistics for the social sciences. London: Lawrence Erlbaum Associates, 1986:1-515.
26. Pietrzik K, Urban G, Hötzel D. Biochemische und hematologische Massstäbe zur Beurteilung des Folatstatus beim Menschen. Int Z Vitamin-Ernaehrungsforsch 1978;48:391-6.
27. Lewis CA, Pancharuniti N, Sauberlich H. Plasma folic acid as determined by homocysteine level. Ann N Y Acad Sci 1992;669: 360-2.
28. Rush, D. Periconceptional folate and neural tube defect. Am J Clin Nutr 1994;59(Suppl 2):511S-6S.
29. Rieder MJ. Prevention of neural tube defects with periconceptional folic acid. Clin Perinatol 1994;21:483-503.